Cargando…
Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230164/ https://www.ncbi.nlm.nih.gov/pubmed/36315007 http://dx.doi.org/10.1182/bloodadvances.2022008625 |
_version_ | 1785051463951581184 |
---|---|
author | Saliba, Antoine N. Kaufmann, Scott H. Stein, Eytan M. Patel, Prapti A. Baer, Maria R. Stock, Wendy Deininger, Michael Blum, William Schiller, Gary J. Olin, Rebecca L. Litzow, Mark R. Lin, Tara L. Ball, Brian J. Boyiadzis, Michael M. Traer, Elie Odenike, Olatoyosi Arellano, Martha L. Walker, Alison Duong, Vu H. Kovacsovics, Tibor Collins, Robert H. Shoben, Abigail B. Heerema, Nyla A. Foster, Matthew C. Peterson, Kevin L. Schneider, Paula A. Martycz, Molly Gana, Theophilus J. Rosenberg, Leonard Marcus, Sonja Yocum, Ashley O. Chen, Timothy Stefanos, Mona Mims, Alice S. Borate, Uma Burd, Amy Druker, Brian J. Levine, Ross L. Byrd, John C. Foran, James M. |
author_facet | Saliba, Antoine N. Kaufmann, Scott H. Stein, Eytan M. Patel, Prapti A. Baer, Maria R. Stock, Wendy Deininger, Michael Blum, William Schiller, Gary J. Olin, Rebecca L. Litzow, Mark R. Lin, Tara L. Ball, Brian J. Boyiadzis, Michael M. Traer, Elie Odenike, Olatoyosi Arellano, Martha L. Walker, Alison Duong, Vu H. Kovacsovics, Tibor Collins, Robert H. Shoben, Abigail B. Heerema, Nyla A. Foster, Matthew C. Peterson, Kevin L. Schneider, Paula A. Martycz, Molly Gana, Theophilus J. Rosenberg, Leonard Marcus, Sonja Yocum, Ashley O. Chen, Timothy Stefanos, Mona Mims, Alice S. Borate, Uma Burd, Amy Druker, Brian J. Levine, Ross L. Byrd, John C. Foran, James M. |
author_sort | Saliba, Antoine N. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10230164 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The American Society of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-102301642023-06-01 Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates Saliba, Antoine N. Kaufmann, Scott H. Stein, Eytan M. Patel, Prapti A. Baer, Maria R. Stock, Wendy Deininger, Michael Blum, William Schiller, Gary J. Olin, Rebecca L. Litzow, Mark R. Lin, Tara L. Ball, Brian J. Boyiadzis, Michael M. Traer, Elie Odenike, Olatoyosi Arellano, Martha L. Walker, Alison Duong, Vu H. Kovacsovics, Tibor Collins, Robert H. Shoben, Abigail B. Heerema, Nyla A. Foster, Matthew C. Peterson, Kevin L. Schneider, Paula A. Martycz, Molly Gana, Theophilus J. Rosenberg, Leonard Marcus, Sonja Yocum, Ashley O. Chen, Timothy Stefanos, Mona Mims, Alice S. Borate, Uma Burd, Amy Druker, Brian J. Levine, Ross L. Byrd, John C. Foran, James M. Blood Adv Research Letter The American Society of Hematology 2022-11-02 /pmc/articles/PMC10230164/ /pubmed/36315007 http://dx.doi.org/10.1182/bloodadvances.2022008625 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Letter Saliba, Antoine N. Kaufmann, Scott H. Stein, Eytan M. Patel, Prapti A. Baer, Maria R. Stock, Wendy Deininger, Michael Blum, William Schiller, Gary J. Olin, Rebecca L. Litzow, Mark R. Lin, Tara L. Ball, Brian J. Boyiadzis, Michael M. Traer, Elie Odenike, Olatoyosi Arellano, Martha L. Walker, Alison Duong, Vu H. Kovacsovics, Tibor Collins, Robert H. Shoben, Abigail B. Heerema, Nyla A. Foster, Matthew C. Peterson, Kevin L. Schneider, Paula A. Martycz, Molly Gana, Theophilus J. Rosenberg, Leonard Marcus, Sonja Yocum, Ashley O. Chen, Timothy Stefanos, Mona Mims, Alice S. Borate, Uma Burd, Amy Druker, Brian J. Levine, Ross L. Byrd, John C. Foran, James M. Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates |
title | Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates |
title_full | Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates |
title_fullStr | Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates |
title_full_unstemmed | Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates |
title_short | Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates |
title_sort | pevonedistat with azacitidine in older patients with tp53-mutated aml: a phase 2 study with laboratory correlates |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230164/ https://www.ncbi.nlm.nih.gov/pubmed/36315007 http://dx.doi.org/10.1182/bloodadvances.2022008625 |
work_keys_str_mv | AT salibaantoinen pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT kaufmannscotth pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT steineytanm pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT patelpraptia pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT baermariar pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT stockwendy pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT deiningermichael pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT blumwilliam pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT schillergaryj pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT olinrebeccal pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT litzowmarkr pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT lintaral pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT ballbrianj pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT boyiadzismichaelm pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT traerelie pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT odenikeolatoyosi pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT arellanomarthal pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT walkeralison pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT duongvuh pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT kovacsovicstibor pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT collinsroberth pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT shobenabigailb pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT heeremanylaa pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT fostermatthewc pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT petersonkevinl pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT schneiderpaulaa pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT martyczmolly pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT ganatheophilusj pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT rosenbergleonard pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT marcussonja pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT yocumashleyo pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT chentimothy pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT stefanosmona pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT mimsalices pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT borateuma pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT burdamy pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT drukerbrianj pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT levinerossl pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT byrdjohnc pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates AT foranjamesm pevonedistatwithazacitidineinolderpatientswithtp53mutatedamlaphase2studywithlaboratorycorrelates |